Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Change in Receivables (2016 - 2026)

Healthequity (HQY) has 13 years of Change in Receivables data on record, last reported at $79000.0 in Q4 2025.

  • For Q4 2025, Change in Receivables rose 104.54% year-over-year to $79000.0; the TTM value through Oct 2025 reached $4.5 million, down 56.97%, while the annual FY2025 figure was $13.1 million, 62.73% up from the prior year.
  • Change in Receivables reached $79000.0 in Q4 2025 per HQY's latest filing, up from -$5.1 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $11.3 million in Q1 2025 and bottomed at -$5.8 million in Q3 2023.
  • Average Change in Receivables over 5 years is $2.2 million, with a median of $1.2 million recorded in 2022.
  • The widest YoY moves for Change in Receivables: up 1971.84% in 2022, down 400.0% in 2022.
  • A 5-year view of Change in Receivables shows it stood at $9.9 million in 2021, then plummeted by 127.48% to -$2.7 million in 2022, then surged by 232.84% to $3.6 million in 2023, then crashed by 148.39% to -$1.7 million in 2024, then surged by 104.54% to $79000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were $79000.0 in Q4 2025, -$5.1 million in Q3 2025, and -$1.8 million in Q2 2025.